Piramal Pharma Solutions, NP2 to complete cyclophosphamide development phase in October

Piramal Pharma Solutions and NP2 will complete the drug development phase for the generic cancer drug cyclophosphamide in October, addressing shortages and supply chain risks. The development and manufacturing are being conducted at Piramal's facility in Lexington, Kentucky.